Crossmark

Tourniquet use in patients with sickle cell trait (SCT): Mediterranean or African ancestry influences complications, demonstrating a higher prevalence than control patients: matched study of nine hundred and forty SCT versus one thousand, two hundred and sixty three non-SCT patients

Crossref DOI link: https://doi.org/10.1007/s00264-025-06555-8

Published Online: 2025-05-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hernigou, Philippe

Vedrenne, Paul

Karam, Sami

Flouzat-Lachaniette, Charles Henri
Funding

Funding for this research was provided by:

Université Paris-Est Créteil
License Information

Text and Data Mining valid from 2025-05-07

Version of Record valid from 2025-05-07
More Information

Article History

Received: 21 April 2025

Accepted: 1 May 2025

First Online: 7 May 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was waived due to the retrospective design of the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below